Kayentis
Created in 2004
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
476 6,955Activities
Technologies
Entity types
Location
19 Chem. du Vieux Chêne, 38240 Meylan, France
Meylan
France
Employees
Scale: 51-200
Estimated: 159
SIREN
451664809Engaged corporates
7
5 3Added in Motherbase
4 years, 7 months ago
biotech Value proposition
Simplify your clinical trial experience
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.
eCOA solutions, Patient engagement, Electronic Clinical Outcome Assessments, Clinical Trials, ePRO, ClinRO, ObsRO, PerfO, eDiary, PRO, DCT solutions, BYOD, and TelevisitOriginal language
Simplify your clinical trial experience
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.
Resources - Kayentis
Explore our latest insights in clinical trials, delve into new trends in eCOA and ePRO trials, understand therapeutic area-specific challenges, discover recent innovations and technologies enhancing user experience and data quality, and much more to empower your studies.
https://kayentis.com/resources/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 11 Apr 2024 | | |
 Groupe Crédit Agricole Bank, Banking | Groupe Crédit Agricole Bank, Banking | Other 13 Apr 2023 | | |
 Avolta Finance, Investment Banking | Avolta Finance, Investment Banking | Other 3 Apr 2023 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 29 Nov 2018 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 20 Dec 2023 | | |
 inovallée, Grenoble Alpes Technopole NGO, Think Tank, Business Consulting and Services | inovallée, Grenoble Alpes Technopole NGO, Think Tank, Business Consulting and Services | Not capitalistic Not partnership Event 30 Jan 2018 1 Jul 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Not capitalistic Partnership Event 16 Nov 2021 11 Aug 2023 | | |